U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute Niagen (nicotinamide riboside chloride) IV and injections to 14 new clinics LOS ANGELES--(BUSINESS ...
(RTTNews) - Hikma Pharmaceuticals plc (HIK.L, HKMPY, HKMPF) announced Monday the launch of COMBOGESIC IV (acetaminophen and ibuprofen) injection in the US. COMBOGESIC IV is an intravenous, opioid-free ...
The benefit of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) as salvage treatment for relapsing multiple myeloma (MM) Bortezomib (Bz) is a novel proteasome ...
The U.S. Food and Drug Administration has expanded the approval of Cinvanti injectable emulsion to include a two-minute intravenous use for the prevention of acute and delayed chemotherapy-induced ...
Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion and deterring infringers Under its ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
Walk into a Miami med spa and leave with “brighter, more even skin tone” delivered via exosome microneedle injections in your face. Or visit a Winter Haven med spa and get ...
LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, is excited to announce the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results